Defending King's performance is an absolute joke. It is basically indefensible.
Let's play connect the dots...
14 months into the Pancreatic trial, Peregrine feels the need to "expand the trial sites" overseas to help in completing the 70 patient requirement. While I understand the difficulty and competition in getting volunteer's in these trials, that fact that we are not fully enrolled this far is sad. King's inability to drum up enthusiasm regarding patient enrollment is pretty telling of his "believability". I guess this is the net result when you cry wolf n' number of times with no results. Presently, his success rate of projections is running neck and neck with Blutarski's GPA on Animal House....and here we stand at $.47 staring at another reverse split...and they somehow all get to keep their jobs.
We need a wholesale change in management who is on the same page as the shareholders.
The market still values Cotara and Bavi AC at basically nothing. Wonder why. Look at the incompetents running the place. Maybe we can still prevail with positive upcoming Lung and Cotara news.
All IMHO.